This patent document relates to analyte testing devices and related techniques.
Analyte testing and monitoring devices play a critical role in modem diagnosis and management of health-related issues. An analyte, or component (in clinical chemistry), is a substance or chemical constituent that is of interest in an analytical procedure. For example, a sample of human blood, urine, and/or saliva can be tested for glucose, fructosamine, hematocrit, hemoglobin blood oxygen saturation, lactates, iron, pH, cholesterol, liver enzymes (e.g., aspartate aminotransferase (AST), alanine aminotransferase (ALT), alkaline phosphatase (ALP)/gamma glutamyl transferase (GOT), lactate dehydrogenase (LDH), bilirubin, etc.), hormones, and/or other compounds.
Techniques, systems, and devices are disclosed for analyte monitoring having a blood sample acquisition module and color touch screen interactive display unit to provide a patient interface for analyte testing.
In one aspect, an analyte testing device includes an analyte sensor module configured to hold a sensor cassette structured to store analytc sensors, the analyte sensor module including an opening from which an analyte sensor advances to a testing position to expose at least a portion of the analyte sensor to outside of the analyte testing device; a lancing module configured to hold a lancet cassette structured to store lancets and project the lancets to outside of the analyte testing device during a blood sample acquisition event to pierce a user's skin; a sensor module in communication with the lancing module, the sensor module including one or more sensors to detect one or more of a lancing projection operation of the device, presence or absence of a lancet in the lancet cassette, or a position or movement of the lancet cassette; a processing unit in communication with the sensor module and configured to determine information associated with the detected lancing projection operation, presence or absence of the lancet in the lancet cassette, or the position or movement of the lancet cassette; and an interactive display unit in communication with the processing unit and including a color touch screen display to receive user inputs from a user and to display the determined information to the user of the device.
This and other aspects and their implementations are described in detail in the drawings, the description and the claims,
Devices, systems and technologies described in this patent document can be implemented to measure properties of analytes such as glucose concentration in blood samples. Various glucose meters and lancing devices on the market today tend to involve multiple devices, components, and supplies, and often require numerous steps to monitor glucose levels. When such devices are designed for patient uses outside the clinical settings or hospitals, the complexity in operating the devices and performing the measurements may lead to patient operation errors and false data and may also cause patient frustration and reluctance in routine use of such devices. For example, some glucose monitoring systems may require numerous steps involving reading a test strip, readying a lancet, using the lancet, putting blood on the test strip and inserting the strip into the glucose meter, reading data from a meter, recording the data in a journal and remembering to bring the journal to the next doctor visit, and then putting away the strip and lancet packages, disposing of loose components, and storing the glucose meter. Thus, it would be beneficial to patients, caregivers, and payers to reduce steps, consolidate devices, and simplify user interfaces for monitoring analytes, e.g., such as glucose in the blood.
Devices, systems, and techniques are disclosed for analyte testing having a blood sample acquisition module to ensure a single sample-taking by a user and interactive display unit to provide a patient interface for analyte testing.
While the disclosed embodiments are described herein primarily based on glucose monitoring to facilitate understanding of the underlying concepts, it is understood that the disclosed embodiments can also include monitoring of other analytes that include, but are not limited to, fructosamine, hematocrit, hemoglobin blood oxygen saturation, lactates, iron, pH, cholesterol, liver enzymes (e.g., AST, ALT, ALP/GGT, LDH, bilirubin, etc.), hormones, and other compounds. For example, other biomolecular substances can also be monitored using analytical monitoring techniques of the disclosed embodiments, which include, but are not limited to, nucleic acids, lipids, carbohydrates, peptides, proteins, enzymes, hormones, antibodies, glycoproteins, glycolipids, organelles, endotoxins, and viruses, among other biological materials and biomarkers.
As shown in
As shown in the schematic illustration of
As shown in the schematic illustration of
As shown in the schematic illustration of
In some implementations, for example, the pawl 140 can be configured to have a spring to allow clutching to the lancet cassette 130 when it recirculates to the nominal start position. In the example shown in
The interactive display unit 160 can be implemented to keep and/or display the count of unused lancets remaining in the lancet cassette 130. For example, in an exemplary ‘new test’ scenario, a user actuated button of the display unit 160 can contact a switch to confirm new test has initiated. The processing unit 150 (e.g., MCU) can look for a state change with the sensor switch 141 to confirm that a lancet 121 has advanced. If no change is detected, for example, the processing unit 150 can change the display image on the color touch screen display 104 to show a “pop-up” warning, which can require user validation. If change is confirmed, for example, the active counter can be modified.
Implementations of the subject matter and the functional operations described in this patent document can be implemented in various systems, digital electronic circuitry, or in computer software, firmware, or hardware, including the structures disclosed in this specification and their structural equivalents, or in combinations of one or more of them. Implementations of the subject matter described in this specification can be implemented as one or more computer program products, i.e., one or more modules of computer program instructions encoded on a tangible and non-transitory computer readable medium for execution by, or to control the operation of, data processing apparatus. The computer readable medium can be a machine-readable storage device, a machine-readable storage substrate, a memory device, a composition of matter affecting a machine-readable propagated signal, or a combination of one or more of them. The term “data processing apparatus” encompasses all apparatus, devices, and machines for processing data, including by way of example a programmable processor, a computer, or multiple processors or computers. The apparatus can include, in addition to hardware, code that creates an execution environment for the computer program in question, e.g., code that constitutes processor ironware, a protocol stack, a database management system, an operating system, or a combination of one or more of them.
A computer program (also known as a program, software, software application, script, or code) can be written in any form of programming language, including compiled or interpreted languages, and it can be deployed in any form, including as a stand-alone program or as a module, component, subroutine, or other unit suitable for use in a computing environment. A computer program does not necessarily correspond to a file in a file system. A program can be stored in a portion of a file that holds other programs or data (e.g., one or more scripts stored in a markup language document), in a single file dedicated to the program in question, or in multiple coordinated files (e.g., files that store one or more modules, sub programs, or portions of code). A computer program can be deployed to be executed on one computer or on multiple computers that are located at one site or distributed across multiple sites and interconnected by a communication network.
The processes and logic flows described in this specification can be performed by one or more programmable processors executing one or more computer programs to perform functions by operating on input data and generating output. The processes and logic flows can also be performed by, and apparatus can also be implemented as, special purpose logic circuitry, e.g., an FPGA (field programmable gate array) or an ASIC (application specific integrated circuit).
Processors suitable for the execution of a computer program include, by way of example, both general and special purpose microprocessors, and any one or more processors of any kind of digital computer. Generally, a processor will receive instructions and data from a read only memory or a random access memory or both. The essential elements of a computer are a processor for performing instructions and one or more memory devices for storing instructions and data. Generally, a computer will also include, or be operatively coupled to receive data from or transfer data to, or both, one or more mass storage devices for storing data, e.g., magnetic, magneto optical disks, or optical disks. However, a computer need not have such devices. Computer readable media suitable for storing computer program instructions and data include all forms of nonvolatile memory, media and memory devices, including by way of example semiconductor memory devices, e.g., EPROM, EEPROM, and flash memory devices. The processor and the memory can be supplemented by, or incorporated in, special purpose logic circuitry.
While this patent document contains many specifics, these should not be construed as limitations on the scope of any invention or of what may be claimed, but rather as descriptions of features that may be specific to particular embodiments of particular inventions. Certain features that are described in this patent document in the context of separate embodiments can also be implemented in combination in a single embodiment. Conversely, various features that are described in the context of a single embodiment can also be implemented in multiple embodiments separately or in any suitable subcombination, Moreover, although features may be described above as acting in certain combinations and even initially claimed as such, one or more features from a claimed combination can in some cases be excised from the combination, and the claimed combination may be directed to a subcombination or variation of a subcombination.
Similarly, while operations are depicted in the drawings in a particular order, this should not be understood as requiring that such operations be performed in the particular order shown or in sequential order, or that all illustrated operations be performed, to achieve desirable results. Moreover, the separation of various system components in the embodiments described in this patent document should not be understood as requiring such separation in all embodiments.
Only a few implementations and examples are described and other implementations, enhancements and variations can be made based on what is described and illustrated in this patent document.
This patent document claims the benefit of priority of U.S. Provisional Patent Application No. 61/952,070, entitled “ANALYTE TESTING DEVICES WITH LANCET ADVANCEMENT TRACKING AND COLOR TOUCH SCREEN USER INTERFACE,” filed on Mar. 12, 2014. The entire disclosure of application 61/952,070 is incorporated herein by reference for all purposes.
Filing Document | Filing Date | Country | Kind |
---|---|---|---|
PCT/US2015/020283 | 3/12/2015 | WO | 00 |
Number | Date | Country | |
---|---|---|---|
61952070 | Mar 2014 | US |